Literature DB >> 12297123

Protein Z influences the prothrombotic phenotype in Factor V Leiden patients.

Bettina Kemkes-Matthes1, Margareta Nees, Gitta Kühnel, Axel Matzdorff, Karl J Matthes.   

Abstract

Protein Z enhances the inhibition of factor Xa by protein Z-dependent protease inhibitor (ZPI). Thus, diminution of protein Z should induce prothrombotic tendency due to lowered cofactor activity for ZPI. In Factor V Leiden mice, prothrombotic tendency of severe diminution or lack of protein Z was demonstrated. We here present first studies in humans, indicating that diminution of protein Z in factor V Leiden patients aggravates thromboembolic risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297123     DOI: 10.1016/s0049-3848(02)00181-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  18 in total

1.  Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor.

Authors:  Juan Pedro Kusanovic; Jimmy Espinoza; Roberto Romero; Debra Hoppensteadt; Jyh Kae Nien; Chong Jai Kim; Offer Erez; Eleazar Soto; Jawed Fareed; Sam Edwin; Tinnakorn Chaiwerapongsa; Nador G Than; Bo Hyun Yoon; Ricardo Gomez; Zoltan Papp; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-06

Review 2.  The importance of factor Xa regulatory pathways in vascular thromboresistance: focus on protein Z.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

Review 3.  A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis.

Authors:  Francesco Sofi; Francesca Cesari; Rosanna Abbate; Gian Franco Gensini; George Broze; Sandra Fedi
Journal:  Thromb Haemost       Date:  2010-01-13       Impact factor: 5.249

4.  Participation of protein Z-dependent protease inhibitor and protein Z system in the pathomechanism of thrombotic complications.

Authors:  Małgorzata A Gacka; Rafał Małecki; Rajmund Adamiec
Journal:  Int J Angiol       Date:  2010

5.  Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.

Authors:  Xin Huang; Alireza R Rezaie; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

6.  Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.

Authors:  Xin Huang; Yahui Yan; Yizheng Tu; Jeffrey Gatti; George J Broze; Aiwu Zhou; Steven T Olson
Journal:  Blood       Date:  2012-07-11       Impact factor: 22.113

7.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

8.  Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.

Authors:  Jing Zhang; Yizheng Tu; Lan Lu; Nina Lasky; George J Broze
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

9.  Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients.

Authors:  F Sofi; F Cesari; Y Tu; G Pratesi; R Pulli; C Pratesi; G F Gensini; R Abbate; S Fedi; G J Broze
Journal:  J Thromb Haemost       Date:  2009-02-18       Impact factor: 5.824

10.  Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.

Authors:  Alireza R Rezaie; Jong-Sup Bae; Chandrashekhara Manithody; Shabir H Qureshi; Likui Yang
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.